Nurture Genomics, Inc. — Form D/A
Nurture Genomics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2023-08-08. The offering totals $5.0M, of which $1.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-08-08
- Form: D/A
- Accession: 0001949258-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.7M
- Remaining: $3.3M
- Investors: 20
- Date of first sale: 2022-09-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460778
Issuer
- Name: Nurture Genomics, Inc.
- CIK: 0001949258
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: CAMBRIDGE INNOVATION CENTER, 1 BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 6179663216
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Hans Keil | Director | Cambridge, MA |
| Hans Keil | Executive Officer | Cambridge, MA |
| Steffanie Bristol | Executive Officer | Cambridge, MA |
| Robert C Green | Director | Cambridge, MA |
| Robert C Green | Executive Officer | Cambridge, MA |
| David C Feinberg | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More